Results 281 to 290 of about 46,891 (297)

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

Journal of Psychopharmacology, 2011
Lauro Wichert-Ana, Rocio Martin-Santos, Sagnik Bhattacharyya   +2 more
exaly  

Cannabidiol/tacrolimus

Reactions Weekly, 2023
openaire   +1 more source

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

American Journal of Psychiatry, 2018
Phillip McGuire
exaly  

Cannabidiol Adverse Effects and Toxicity

Current Neuropharmacology, 2019
Marilyn A Huestis, Renata Solimini, Simona Pichini   +2 more
exaly  

Cannabidiol/immunosuppressants

Reactions Weekly, 2022
openaire   +1 more source

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

European Journal of Pharmacology, 2007
Barbara Costa
exaly  

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Lancet Neurology, The, 2016
Orrin Devinsky, Daniel Friedman, Linda Laux   +2 more
exaly  

Synthetic Cannabidiol Poisoning

JAMA, 2018
openaire   +2 more sources

Brivaracetam/cannabidiol

Reactions Weekly, 2023
openaire   +1 more source

cannabidiol, n.

2023
openaire   +1 more source